Kevin Maclay Discusses Tort Liabilities at AIRA Advanced Restructuring & POR Conference

11.15.2021

Since June 2019, three opioid manufacturers – Insys, Purdue, and Mallinckrodt – have filed for chapter 11, due in large part to the onslaught of litigation they have faced amidst the nationwide opioid epidemic. Unlike almost every other mass tort-induced chapter 11 filing prior thereto, the litigation that accelerated these chapter 11’s was brought mainly by “public” side plaintiffs – States and Political Subdivisions – as well as “private” side plaintiffs, such as personal injury victims. The objective of this panel – comprised of advisors to States, Political Subdivisions, Personal Injury Victims, and the Official Committee in each case, as well as one principal from the State of NY’s AG office – is to discuss key these issues as best as they can, given the sensitivities and then-current status of each of these cases.

Attorneys

Related Practices/Industries

Jump to Page

We use cookies to make your experience of our website better. By continuing to browse this site you content to the use of cookies. Please visit our Privacy Policy for more information.